Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login

Adenovirus Packaging

Adenovirus (AdV) is a widely used viral vector for gene delivery, offering high transduction efficiency, broad tropism, and transient gene expression. With scalable production and purification options, Cyagen’s AdV packaging service delivers high-quality viral vectors optimized for both in vitro and in vivo applications.
High-Titer & Scalable Production
Purified virus up to 1×10¹² PFU/mL for diverse applications.
Non-Integrating & Safe
Transient expression avoids risks of genome integration and mutations.
High Transduction Efficiency
Achieves robust gene expression in dividing and non-dividing cells.
Overview
Workflow
FAQs
Overview
Versatile Adenoviral Vectors for Gene Delivery
Adenovirus (AdV) is a powerful viral vector system known for its high gene expression levels, large transgene capacity (up to 7-8kb), and broad host range. Unlike integrating viral vectors, AdV maintains its DNA episomally, reducing the risk of genetic alterations in host cells.

Due to its efficient transduction ability, AdV is widely used for gene therapy, vaccine development, and functional genomics studies. Cyagen’s adenoviral packaging service provides ready-to-use, high-titer vectors tailored to meet different research needs.
Explore Ready-to-Use Mouse Models
Discover over 18,000 validated mouse strains—including knockout, conditional knockout, and humanized models—covering 20+ research areas such as oncology, neurology, and metabolism. All models are supported by detailed genotype data and guaranteed quality, helping you fast-track discovery with confidence.
You Might Also Be Interested In
Knockout Cell Lines Library
Browse validated human KO cell lines by gene or cell type
Tumor Cell Lines Library
Access characterized human tumor lines by cancer type or genetic status.
AAV Vectors Library
Search and order AAVs by serotype, gene, or function
MouseAtlas Model Library
Search and access curated genetically engineered mouse strains
Cell Immunotherapy CRO Platform
CAR-T/NK development with custom vectors, models, and in vivo validation
Gene Therapy CRO Platform
AI-guided AAV design and full-spectrum preclinical validation
Workflow
Workflow and Delivery
Cyagen’s adenovirus packaging service ensures reliable, high-titer vector production through a streamlined and quality-controlled process.
Service Comparison
Compare our adenovirus packaging options to find the best fit for your research needs, whether for in vitro studies or in vivo applications.
Type Titer Quality Control Turnaround Application
Standard Adenovirus ≥1×10¹⁰ PFU/mL qPCR, functional validation 7-10 weeks Cell transduction
Purified Adenovirus ≥1×10¹² PFU/mL qPCR, ELISA, endotoxin test 7-10 weeks In vivo studies
Workflow & Timeline
Our optimized workflow delivers high-purity adenoviral vectors with rapid turnaround, ensuring consistency and efficiency for your research.
Stage Description Timeframe
Plasmid Preparation Construction of expression and helper plasmids 1 week
Transfection & Virus Production 293 cells transfected for high-yield virus production 2-3 weeks
Virus Harvesting & Purification Standard and purified virus options available 1-2 weeks
Titer Quantification & QC qPCR, functional validation, endotoxin testing (if required) 1-2 weeks
Final Packaging & Delivery Sterility testing, cryopreservation, and shipment 1 week
Notes: Total Turnaround: 7-10 weeks (varies based on purification and titer requirements).
FAQs
Frequently Asked Questions (FAQs)
What is the advantage of using adenovirus for gene delivery?
Adenovirus offers high transduction efficiency in most mammalian cells, does not require active cell division, and enables high transient gene expression.
What is the typical viral titer for Cyagen’s adenovirus packaging service?
We offer standard adenovirus with titers ≥1×10¹⁰ PFU/mL and purified virus up to ≥1×10¹² PFU/mL.
Is Cyagen’s adenovirus suitable for in vivo applications?
Yes, our purified adenovirus production meets quality control standards suitable for in vivo research.
What quality control tests are performed on packaged adenovirus?
We conduct qPCR for viral genome quantification, functional transduction validation, and optional endotoxin testing.
How should I store my adenovirus upon delivery?
We recommend storing adenovirus at -80°C to maintain stability and titer.
Citation Database
Molecular Therapy: Methods & Clinical Development, March, 2025
Intracranial AAV administration dose-dependently recruits B cells to inhibit the AAV redosing
【Other】
Gut, February, 2025
E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression
【Other】
Cell Death & Disease, February, 2025
Mcm5 mutation leads to silencing of Stat1-bcl2 which accelerating apoptosis of immature T lymphocytes with DNA damage
【Other】
Molecular Therapy, February, 2025
Single-cell data-driven design of armed oncolytic virus to boost cooperative innate-adaptive immunity against cancer
【Other】
Request a Virus Packaging Service Consultation
Get expert guidance for your viral vector production needs. Submit your project details and we'll assist you promptly.
Inquiry Details
Main Area of Research
Service(s) of Interest
Vector Type & Application
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research